Trabectedina en Sarcomas de Partes Blandas ¿Cuándo y a quién? - page 28

65 (23%)
HT = 28 (10%)
S = 37 (13%)
MLPS LMS Synov Sa UPS MPNST
97 (34%)
HT = 52 (18%)
S = 45 (16%)
70 (24%)
HT = 34 (12%)
S = 36 (12%)
26 (9%)
HT = 12 (4%)
S = 15 (5%)
28 (10%)
HT = 16 (6%)
S = 12 (4%)
286 pacientes: Histología